Latest news with #lungcondition
Bloomberg
3 days ago
- Health
- Bloomberg
Insmed Drug Wins First US Approval for Debilitating Lung Disease
US regulators have approved the first drug to treat a debilitating lung condition, ending two centuries of waiting and paving the way for a potential blockbuster from Insmed Inc. The once-daily pill, called Brinsupri and known chemically as brensocatib, eases bronchiectasis, a chronic inflammatory disease that damages the airways and can make it hard to breathe. Patients struggle to clear mucus from their lungs, which creates a breeding ground for infections and often lands them in the hospital for long periods.
Bloomberg
21-07-2025
- Health
- Bloomberg
Roche Suffers Setback as Lung Drug Gets Mixed Result in Trial
Roche Holding AG 's experimental drug for a deadly lung condition got mixed results in trials, a setback as the company seeks to accelerate the development of new treatments. The late-stage trials for astegolimab — the medicine being developed to treat chronic obstructive pulmonary disease, or COPD — offered contrasting results, according to a statement on Monday.
Bloomberg
30-05-2025
- Business
- Bloomberg
Stock Movers: Sanofi Down, M&G Up, Gap Down (podcast)
On this episode of Stock Movers: - Sanofi shares fall following mixed results of its experimental drug for a deadly lung condition. - M&G's shares gain as much as 8.6% to reach the highest since June 2021, after Dai-ichi Life Holdings said it will acquire a 15% stake in the UK life insurer. - Asian clothing-related stocks slip, amid broad market weakness, after Gap reported a tariff impact of as much as $300 million.
